These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 14963110)

  • 1. Identification of a functional vitamin D response element in the human insulin-like growth factor binding protein-3 promoter.
    Peng L; Malloy PJ; Feldman D
    Mol Endocrinol; 2004 May; 18(5):1109-19. PubMed ID: 14963110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
    Raval-Pandya M; Freedman LP; Li H; Christakos S
    Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
    Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R
    J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element.
    Kuno H; Kurian SM; Hendy GN; White J; deLuca HF; Evans CO; Nanes MS
    Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single up-stream element confers responsiveness to 1,25-dihydroxyvitamin D3 and tumor necrosis factor-alpha in the rat osteocalcin gene.
    Nanes MS; Kuno H; Demay MB; Kurian M; Hendy GN; DeLuca HF; Titus L; Rubin J
    Endocrinology; 1994 Mar; 134(3):1113-20. PubMed ID: 8119149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor binding protein-5 interacts with the vitamin D receptor and modulates the vitamin D response in osteoblasts.
    Schedlich LJ; Muthukaruppan A; O'Han MK; Baxter RC
    Mol Endocrinol; 2007 Oct; 21(10):2378-90. PubMed ID: 17595320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of the vitamin D receptor with a vitamin D response element in the Mullerian-inhibiting substance (MIS) promoter: regulation of MIS expression by calcitriol in prostate cancer cells.
    Malloy PJ; Peng L; Wang J; Feldman D
    Endocrinology; 2009 Apr; 150(4):1580-7. PubMed ID: 19056816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor binding protein-3 modulates osteoblast differentiation via interaction with vitamin D receptor.
    Li J; Jin D; Fu S; Mei G; Zhou J; Lei L; Yu B; Wang G
    Biochem Biophys Res Commun; 2013 Jul; 436(4):632-7. PubMed ID: 23770368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An essential role of the CAAT/enhancer binding protein-alpha in the vitamin D-induced expression of the human steroid/bile acid-sulfotransferase (SULT2A1).
    Song CS; Echchgadda I; Seo YK; Oh T; Kim S; Kim SA; Cho S; Shi L; Chatterjee B
    Mol Endocrinol; 2006 Apr; 20(4):795-808. PubMed ID: 16357103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element.
    Imai Y; Pike JW; Koeffler HP
    Leuk Res; 1995 Mar; 19(3):147-58. PubMed ID: 7700077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of human placental lactogen expression by 1,25-dihydroxyvitamin D3.
    Stephanou A; Ross R; Handwerger S
    Endocrinology; 1994 Dec; 135(6):2651-6. PubMed ID: 7988455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of vitamin D responsive elements in normal and transformed keratinocytes.
    Xie Z; Bikle DD
    J Invest Dermatol; 1998 May; 110(5):730-3. PubMed ID: 9579536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct regulation of HOXA10 by 1,25-(OH)2D3 in human myelomonocytic cells and human endometrial stromal cells.
    Du H; Daftary GS; Lalwani SI; Taylor HS
    Mol Endocrinol; 2005 Sep; 19(9):2222-33. PubMed ID: 15905361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the human osteocalcin gene by 24R,25-dihydroxyvitamin D3 occurs through the vitamin D receptor and the vitamin D-responsive element.
    Uchida M; Ozono K; Pike JW
    J Bone Miner Res; 1994 Dec; 9(12):1981-7. PubMed ID: 7872065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA sequences downstream from the vitamin D response element of the rat osteocalcin gene are required for ligand-dependent transactivation.
    Sneddon WB; Bogado CE; Kiernan MS; Demay MB
    Mol Endocrinol; 1997 Feb; 11(2):210-7. PubMed ID: 9013768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transrepression of the estrogen receptor promoter by calcitriol in human breast cancer cells via two negative vitamin D response elements.
    Swami S; Krishnan AV; Peng L; Lundqvist J; Feldman D
    Endocr Relat Cancer; 2013 Aug; 20(4):565-77. PubMed ID: 23744764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cells.
    Meyer MB; Watanuki M; Kim S; Shevde NK; Pike JW
    Mol Endocrinol; 2006 Jun; 20(6):1447-61. PubMed ID: 16574738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro binding of vitamin D receptor occupied by 24R,25-dihydroxyvitamin D3 to vitamin D responsive element of human osteocalcin gene.
    Uchida M; Ozonco K; Pike JW
    J Steroid Biochem Mol Biol; 1997 Feb; 60(3-4):181-7. PubMed ID: 9191975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
    Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
    Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.